Home Page
CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses
Indian drug regulators ordered Sun Pharma to halt eye-care drug production at its Assam plant over quality lapses, following the recall of 332 batches of ophthalmic products.
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.